Diasorin Deutschland GMBH
Dietzenbach, HE
- UEI
- GF23JDET8KB8
- CAGE
- DA258
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- Von-Hevesy-Straße 3, 63128 Dietzenbach, Germany
- Website
- diasorin.com
- Founded
- 2000
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $147,743 |
| FY2025 | $148,445 |
| FY2024 | $0 |
| FY2023 | $146,514 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $147,743 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| RPP nxtag( IVD-US) 96 tests RPP nxtag( IVD-US) 96 tests lumenix respiratory pathogen panel nxtag (IVD-US) 96 tests… | Defense Health Agency | $147,743 | |
| RPP nxtag( IVD-US) 96 tests | Medical Command (Army) | $148,445 | |
| RPP nxtag( IVD-US) 96 tests | Medical Command (Army) | $146,514 |
Similar vendors
About the company
Diasorin Deutschland GMBH, a foreign-owned for-profit manufacturer of in-vitro diagnostic products based in Dietzenbach, Germany, has been registered in SAM.gov since September 2005 and serves as a prime contractor to the U.S. federal government. The company specializes in manufacturing medical diagnostic testing supplies and laboratory equipment, with a primary focus on supporting U.S. military medical operations through the Defense Health Agency. As a Germany-based manufacturer, Diasorin Deutschland GMBH is well-positioned to provide rapid procurement and delivery of specialized diagnostic products to U.S. military medical facilities in the European theater.
Diasorin Deutschland GMBH has received three delivery order contracts from the Defense Health Agency valued at $158,811.97, $148,444.76, and $146,514.23, respectively, all awarded without set-aside designations and structured as firm fixed-price contracts. All delivery orders are for the procurement of RPP NXTAG (IVD-US) 96 test kits, which are respiratory pathogen panel diagnostic tools used for rapid identification of multiple respiratory pathogens in clinical laboratory settings. The most recent delivery order, awarded on October 1, 2025, has an ultimate completion date of September 30, 2026, while the two prior orders were awarded on December 1, 2024, and September 5, 2023, with completion dates of September 30, 2025, and September 4, 2024, respectively. All three delivery orders support laboratory operations at Landstuhl Regional Medical Center (LRMC) in Germany, a major U.S. military medical facility. The company has performed no subcontracted work and has not utilized any federal contract vehicles or set-aside designations, indicating direct acquisition of its specialized medical diagnostic products.
Diasorin Deutschland GMBH holds a single-award indefinite delivery contract with the Defense Health Agency valued at $732,571.15, with a period of performance through September 4, 2028. This IDV was awarded on September 5, 2023, without any set-aside designation and provides a framework for the ongoing procurement of medical testing supplies and laboratory equipment to support Landstuhl Regional Medical Center. The contract specifically covers the provision of RPP NXTAG (IVD-US) 96 test kits and is structured to enable the Defense Health Agency to issue delivery orders as operational needs require. As of January 2026, three delivery orders have been issued under this IDV, with the most recent order issued on October 1, 2025, demonstrating sustained demand for the company's specialized diagnostic products in support of U.S. military medical operations in the European theater.
Quick answers
Is Diasorin Deutschland GMBH registered in SAM.gov?
Yes. Diasorin Deutschland GMBH's SAM.gov registration is active through November 17, 2026.
How much has Diasorin Deutschland GMBH received in federal contracts?
Federal contracts obligated $148,445 to Diasorin Deutschland GMBH in fiscal year 2025 and $442,702 in fiscal years 2023 through 2027.
What is Diasorin Deutschland GMBH's most recent federal award?
Diasorin Deutschland GMBH's most recent federal contract award is RPP nxtag( IVD-US) 96 tests RPP nxtag( IVD-US) 96 tests lumenix respiratory pathogen panel nxtag (IVD-US) 96 tests… (W9114F25FA065), from Defense Health Agency, on October 1, 2025.
On GovTribe
See Diasorin Deutschland GMBH's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors